Articles Written by:    RICHARD GALLAGHER     

« Previous  |  Next »

Memo to moneybags

A relatively small additional investment could end up with a big payout for the investor and the region. One of my fantasies is to own Celtic Football Club, a storied club based in Glasgow. So I can’t find it in me to outright criticize Sheikh Mansour ...

From RICHARD GALLAGHER, The Scientist,  15 Oct 2009
Related Topics: Celtic FC,  Wikipedia,  Mercedes-Benz,  Porsche

Aid for poverty -- and pudding

Not for nothing is micronutrient malnutrition known as the “hidden hunger.” At my school dining hall in 1970s Scotland, tapioca was sometimes served as pudding. It has since fallen out of favor as a culinary treat, and I can’t say I’m surprised. ...

From RICHARD GALLAGHER, The Scientist,  14 Sep 2009
Related Topics: Bob Grant,  Michael Pollan,  Vandana Shiva

Bailed out by science

Science won’t feature extensively in talks over the coming weeks, but it is central to effectively rehabilitate the healthcare system. It’s a daunting task, but the ailing beast that is the US healthcare system must be brought to heel. Its feverish ...

From RICHARD GALLAGHER, The Scientist,  4 Aug 2009
Related Topics: Amgen Inc.

Fairness for fraudsters

At the end of the exclusion period, researchers should be able to participate again as full members of the scientific community. But they can't. The Office of Research Integrity (ORI), part of the US Public Health Service (PHS), serves an indispensible ...

From RICHARD GALLAGHER, The Scientist,  2 Jul 2009

For shame, Merck and Elsevier

It was a stealth marketing campaign to Australian doctors under the guise of a regular journal. Merck and Elsevier, two life sciences giants, are taking different tacks in responding to a crisis that arose from an ill-judged publishing collaboration. ...

From RICHARD GALLAGHER, The Scientist,  2 Jun 2009
Related Topics: Merck & Company, Inc.,  Bob Grant

Citation violations

The age-old problem of attribution in science—in other words, the practice of citation—has resurfaced with a vengeance in a couple of recent fracases. What's new about these cases is that they're being played out online in full gory detail and in real ...

From RICHARD GALLAGHER, The Scientist,  6 May 2009

The people's lab

I sit on the advisory board of an art gallery that exhibits contemporary artists who engage with science and technology. Last December, the curator had some exciting news in his end-of-year email: His gallery was proposing to join forces with a ...

From RICHARD GALLAGHER, The Scientist,  3 Mar 2009
Related Topics: Freeman Dyson

Back in black

The life sciences are ubiquitous. Their application in medicine (known in some quarters as red biotechnology), agriculture (green biotech) and industrial processes (white biotech) is indispensible and lauded. In this issue we look at a no less ...

From RICHARD GALLAGHER, The Scientist,  2 Feb 2009
Related Topics: Bob Grant

Innovation imperiled

Healthcare spending in the United States is unsustainable. It topped $2.3 trillion in 2007—that's $7,600 for every man, woman and child. That wouldn't be quite so hard to swallow if the service was excellent, but it's spotty, especially for the 47 ...

From RICHARD GALLAGHER, The Scientist,  31 Dec 2008
Related Topics: Tom Daschle,  U.S. Congress,  Barack Obama

National character and scientific enterprise

Recently, at a party in Oslo for the life sciences community, I was asked to make a few remarks, and decided to blurt out what had come into my head about the trip. Which was given what I'd grasped about the "Norwegian character," the country would ...

From RICHARD GALLAGHER, The Scientist,  1 Dec 2008
Related Topics: European Commission

« Previous  |  Next »

Who is This?

Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.

Suggest an Entry

Enter a url from sourcewatch.org or wikipedia.org:


recommend removal

close